Skip to content
Search

Latest Stories

CCA calls for Pharmacy First expansion to boost antibiotic stewardship and patient care

Pharmacy First data indicates that pharmacists are responsible providers of
gettyimages

Pharmacy First data indicates that pharmacists are responsible providers of antibiotics and they are closely following AMR guidelines

The Company Chemists’ Association (CCA) has urged NHS England to expand the Pharmacy First service by increasing treatment options, adding more conditions, and integrating Independent Prescribing into the service.

This would further promote pharmacists as antimicrobial stewards while enhancing patient access to urgent care, it said.


Managing patient demand for antibiotics remains a challenge for healthcare professionals, including pharmacists.

However, a new report by CCA confirms that pharmacists are acting as responsible providers of antibiotics, in line with Antimicrobial Resistance (AMR) guidelines.

The service allows pharmacies to provide advice and treatment, including prescription-only medication, for seven common conditions: earache, uncomplicated urinary tract infections (UTIs) in women, sore throat, sinusitis, infected insect bites, impetigo, and shingles.

Patients can access the service via GP referrals or by visiting or contacting a pharmacy directly.

The CCA’s analysis of over 150,000 anonymised consultation records from more than 3,000 pharmacies (August-September 2024) revealed that 66 per cent of patients treated for one of the six bacterial conditions received antibiotics (shingles, a viral infection, was excluded).

Around 94 per cent of patients received a complete episode of care without requiring onward referral.

The analysis found that pharmacists were adhering strictly to treatment guidelines, with 88 per cent of antibiotics supplied being first-line treatments, excluding bladder infections where only one treatment option is available through the service.

Additionally, the report showed that when multiple treatment options exist, less than half of patients receive oral antibiotics.

The report noted that adding more treatment options to the service would provide more options to pharmacists and support appropriate antibiotic supply.

To further enhance antibiotic stewardship and expand patient care, the CCA recommends adding more conditions to the Pharmacy First service, such as lower back pain, respiratory tract infections, conjunctivitis, and skin conditions like acne, eczema, and psoriasis.

The CCA also advocates for integrating pharmacist prescribing into the Pharmacy First service, which would “increase the reach and impact, and also further support pharmacists in providing treatment in line with AMS best practice.”

Additionally, it calls for commissioning pharmacies to capture information on patients who do not meet “gateway” criteria.

“This information would enable better understanding of the rate of antibiotics provision through Pharmacy First, as well the workload associated with the service,” the CCA stated.

The service has dramatically increased access to urgent care, particularly in deprived communities, where access to healthcare (including GP appointments) is typically lower.

Between January and September 2024, the Pharmacy First service facilitated over 1.4 million patient appointments that were redirected from general practice via clinical pathway consultations, according to the report.

More For You

Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less